Identification of lenvatinib prognostic index via recursive partitioning analysis in advanced hepatocellular carcinoma
Ilario Giovanni Rapposelli(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Andrea Casadei‐Gardini(Vita-Salute San Raffaele University), Takuji Torimura(Omuta hospital), Kazuhito Kawata(Hamamatsu University School of Medicine), Francesca Salani(Scuola Superiore Sant'Anna), Emiliano Tamburini(Ospedale Infermi di Rimini), Margherita Rimini(Vita-Salute San Raffaele University), Hiroshi Shibata(Social Insurance Saitama Chuo Hospital), Hidenori Toyoda(Ogaki Municipal Hospital), Fabio Piscaglia(Azienda USL di Bologna), Mario Scartozzi(University of Cagliari), Caterina Vivaldi(Scuola Superiore Sant'Anna), Shigeo Shimose(Kurume University), Raffaella Tortora, Atsushi Hiraoka(Ehime Prefectural Central Hospital), Stefano Cascinu(Vita-Salute San Raffaele University), Takashi Kumada(Gifu Kyoritsu University), Valentina Burgio(Vita-Salute San Raffaele University), Claudia Campani(Inserm), Claudia Angela Maria Fulgenzi(Università Campus Bio-Medico), Giorgio Astara(University of Cagliari), Sara Lonardi(Istituto Oncologico Veneto), Mario Domenico Rizzato(University of Padua), Gianluca Masi(University of Pisa), Fabio Conti, Kazuto Tajiri(Toyama University Hospital), Akio Takata(Kurume University), Toshifumi Tada(Himeji Red Cross Hospital), A. Forgione(Azienda USL di Bologna), Eleonora Lai(University of Cagliari), Fabio Marra(Unknown), G.G. Di Costanzo, Masanori Atsukawa(Nippon Medical School), Antonio Pellino(Ospedale di Livorno), Giovanni Luca Frassineti, Marianna Silletta(Università Campus Bio-Medico), Shusuke Okamura(Kurume University), Francesco Giuseppe Foschi, Massimo Viola(Robotic Technology (United States)), Masahito Nakano(Kurume University)
Cited by 20
Related Papers
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
|The Lancet Oncology|2017|2.8k
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
|Journal of Clinical Oncology|2014|2.8k
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer
|Journal of Clinical Oncology|2018|2.1k
Encorafenib, Binimetinib, and Cetuximab in <i>BRAF</i> V600E–Mutated Colorectal Cancer
|New England Journal of Medicine|2019|1.5k
Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2022|1.4k